Orforglipron: The Oral GLP-1 That Could Replace Injectables by 2027
Orforglipron: The Oral GLP-1 That Could Replace Injectables by 2027 There is a medication that is changing the way doctors and patients view the treatment of obesity and type 2 diabetes. Its name is orforglipron, and the big difference between it and the drugs available today on the market is.